India’s COVID-19 Nightmare And How Pharma Is Holding Up

A COVID-19 second wave is wreaking havoc in India but pharma appears to be holding things together for now, stretching resources amid a dip in personnel attendance and supply chain strains. Limited vaccine supplies, a spurt in API prices and an inevitable third wave could mean further turbulence ahead.

Devastating Second Wave Of COVID-19 In India • Source: Alamy

COVID-19 has exposed the shortcomings in India’s rickety healthcare system and is costing the country lives, as well as breaking the resilience that Indians are supposed to have ingrained in coping with various sub-par aspects across the spectrum of health-related services.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Focus On Asia